The Cost Effectiveness of Maintenance Schedules Following Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease: An Economic Evaluation Alongside a Randomised Controlled Trial

详细信息    查看全文

• 作者：Darren K. Burns ; Edward C. F. Wilson…
• 刊名：Applied Health Economics and Health Policy
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：14
• 期：1
• 页码：105-115
• 全文大小：772 KB
• 参考文献：1.National Institute for Health and Clinical Excellence. Chronic obstructive pulmonary disease. Costing report: implementing NICE guidance. NICE clinical guideline 101. London: National Institute for Health and Clinical Excellence; 2010.
  2.National Institute for Health and Clinical Excellence. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. London: National Institute for Health and Clinical Excellence; 2010.
  3.Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64.CrossRef PubMed
  4.Bolton CE, Bevan-Smith EF, Blakey JD, et al. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013;68 Suppl 2:ii1–30.
  5.Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131(5 Suppl):4S–42S.CrossRef PubMed
  6.Beauchamp MK, Evans R, Janaudis-Ferreira T, et al. Systematic review of supervised exercise programs after pulmonary rehabilitation in individuals with COPD. Chest. 2013;144(4):1124–33.CrossRef PubMed
  7.Wilson A, Browne P, Olive S, et al. The effects of maintenance schedules following pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomised controlled trial. BMJ Open. 2015;5(3):e005921.PubMedCentral CrossRef PubMed
  8.Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10):773–8.PubMedCentral CrossRef PubMed
  9.The EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.
  10.Secondary. http://​www.​euroqol.​org/​ . Accessed Aug 2014.
  11.Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35(11):1095–108.CrossRef PubMed
  12.Department of Health. NHS reference costs 2012–13. London: Department of Health; 2013.
  13.Curtis L. Unit costs of health and social care 2013. Canterbury: University of Kent at Canterbury; 2014.
  14.Curtis L. Unit costs of health and social care 2012. Canterbury: University of Kent at Canterbury; 2013.
  15.Office for National Statistics. Annual survey of hours and earnings, 2013 provisional results, 2014.
  16.Office of National Statistics. Consumer price indices. Secondary consumer price indices. 2014. http://​www.​ons.​gov.​uk/​ons/​rel/​cpi/​consumer-price-indices/​may-2014/​cpi-time-series-data.​html . Accessed Aug 2014.
  17.British National Formulary 65: March–September 2013.
  18.Rubin DB. Mutliple imputation for nonresponse in surveys. Hoboken: Wiley; 2004.
  19.Baumann HJ, Kluge S, Rummel K, et al. Low intensity, long-term outpatient rehabilitation in COPD: a randomised controlled trial. Respir Res. 2012;13(1):86.PubMedCentral CrossRef PubMed
  20.van Wetering CR, Hoogendoorn M, Broekhuizen R, et al. Efficacy and costs of nutritional rehabilitation in muscle-wasted patients with chronic obstructive pulmonary disease disease in a community-based setting: a prespecified subgroup analysis of the INTERCOM trial. J Am Med Dir Assoc. 2010;11:179–87.CrossRef PubMed
  21.Griffiths TL, Phillips CJ, Davies S, et al. Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme (Structured abstract). Thorax. 2001;56(10):779–84.PubMedCentral CrossRef PubMed
  22.Gillespie P, O’Shea E, Casey D, et al. The cost-effectiveness of a structured education pulmonary rehabilitation programme for chronic obstructive pulmonary disease in primary care: the PRINCE cluster randomised trial (Provisional abstract). BMJ Open. 2013;3(11):e003479.
  23.Waterhouse JC, Walters SJ, Oluboyede Y, et al. A randomised 2 x 2 trial of community versus hospital pulmonary rehabilitation, followed by telephone or conventional follow-up. Health Technol. Assess. (Winchester, England) 2010;14(6):i–v.
  24.Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. Pharmacoeconomics. 2013;31(5):361–7.CrossRef PubMed
  25.Byford S, Leese M, Knapp M, et al. Comparison of alternative methods of collection of service use data for the economic evaluation of health care interventions. Health Econ. 2007;16(5):531–6.CrossRef PubMed
  26.Patel A, Rendu A, Moran P, et al. A comparison of two methods of collecting economic data in primary care. Fam Pract. 2005;22(3):323–7.CrossRef PubMed
  27.Manca A, Hawkins N, Sculpher MJ. Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 2005;14(5):487–96.CrossRef PubMed
  
• 作者单位：Darren K. Burns (1)
  Edward C. F. Wilson (1) (2)
  Paula Browne (3)
  Sandra Olive (3)
  Allan Clark (4)
  Penny Galey (3)
  Emma Dix (3)
  Helene Woodhouse (3)
  Sue Robinson (3)
  Andrew Wilson (3) (4)
  
  1. Health Economics Group, University of East Anglia, Norwich, NR4 7TJ, UK
  2. Cambridge Centre for Health Services Research, Institute of Public Health, University of Cambridge School of Clinical Medicine, Forvie Site, Robinson Way, Cambridge, CB2 0SR, UK
  3. Department of Respiratory Medicine, Norfolk and Norwich University Hospital NHS Foundation Trust, Colney Lane, Norwich, NR4 7UY, UK
  4. Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK
  
• 刊物主题：Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Health Administration;
• 出版者：Springer International Publishing
• ISSN：1179-1896

文摘

Background Chronic obstructive pulmonary disease (COPD) affects approximately 3 million people in the UK. An 8-week pulmonary rehabilitation (PR) course is recommended under current guidelines. However, studies show that initial benefits diminish over time.